Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,650 signal articles · 32 in last 24h · 155,881 total before filter · latest 2h ago
32last 24h
848last 7d
144● bullish (7d)
87● bearish (7d)
214publishers
AllMacro191Earnings110M&A124Regulatory19Product20Analyst20
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
CVS’s Turnaround Faces Its Next Test
Barrons.com53d agoneutral
CVS’s Turnaround Faces Its Next Test

CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.

Paramount Skydance reports mixed second-quarter results
Reuters53d agoneutral
Paramount Skydance reports mixed second-quarter results

Paramount Skydance reported mixed second-quarter results on Tuesday, with higher streaming and studio revenue offsetting declines in television, as the company works to close its ‌planned $110 billion acquisition of Warner Bros. Discovery. Ellison reiterated that ​he fully expects "the transaction to close."

Lucid Q2 results: Losses widen as automaker launches 'operational reset'
Yahoo Finance53d agoneutral
Lucid Q2 results: Losses widen as automaker launches 'operational reset'

Lucid reported second-quarter results on Tuesday that beat revenue expectations but losses ran wider than expected, as the struggling luxury EV maker unveiled an "operational reset" aimed at slashing cash burn, and stabilizing a business that recently had to publicly deny it was heading for bankruptcy.

Apollo Global Management Q2 Earnings Call Highlights
MarketBeat53d agoneutral
Apollo Global Management Q2 Earnings Call Highlights

Apollo Global Management (NYSE:APO) reported record second-quarter fee-related earnings and spread-related earnings, citing momentum in origination, capital formation and investment performance across its asset management and retirement services businesses. The alternative asset manager generated f

Aptiv Q2 Earnings Call Highlights
MarketBeat53d agoneutral
Aptiv Q2 Earnings Call Highlights

Aptiv (NYSE:APTV) reported second-quarter results that included 2% adjusted revenue growth and 10 basis points of adjusted EBITDA margin expansion, while lowering its full-year outlook amid weaker automotive production schedules in China and delayed program launches. Chair and CEO Kevin Clark said

Albany International Q2 Earnings Call Highlights
MarketBeat53d agoneutral
Albany International Q2 Earnings Call Highlights

Albany International (NYSE:AIN) reported second-quarter revenue growth and its strongest adjusted EBITDA performance in two years, driven by higher production rates in its Engineered Composites business, while Machine Clothing faced mixed regional demand and equipment-related downtime. Total second

Amazon loses US court ban on Perplexity's AI shopping tools
Reuters53d agoneutral
Amazon loses US court ban on Perplexity's AI shopping tools

A U.S. appeals court on Tuesday overturned a ruling that had temporarily barred Perplexity from using its AI-powered agentic shopping tools on ‌Amazon's platform. In a novel legal dispute, the San Francisco-based 9th U.S. Circuit Court ‌of Appeals determined that Amazon was unlikely to succeed on its claim that Perplexity's AI agents violated a federal ​computer-hacking law. The ruling is the first by a federal appeals court to address whether AI agents acting on behalf of users can legally access online platforms, a question with broad implications for the fast-growing field of agentic AI tools that can browse, shop and transact across the web.

Antitrust Trial Over Paramount-Warner Merger Set for March
The Wall Street Journal53d agoneutral
Antitrust Trial Over Paramount-Warner Merger Set for March

A California federal judge said Tuesday that the antitrust trial will begin March 2 with an expectation that it will run for 12 court days. The timeline the judge laid out in a written order is much later than the November 2026 start date Paramount had sought. The order will prove costly for Paramount.